Molecular probes for the in vivo imaging of cancer

Keywords

Molecular imaging, Positron emission tomography, Preclinical imaging, Magnetic resonance imaging, In vivo

References

• Fluorescence lifetime spectroscopy in multiply scattering media with dyes exhibiting multiexponential decay kinetics.淳一 青木, 一郎 丸山 — 2002
• What's new in imaging? New magnetic resonance imaging of esophageal cancer using an endoluminal surface coil and antibody-coated magnetite particles.Soji Ozawa, Yutaka Imai, Tatsushi Suwa — 2000
• Fluorescence lifetime-resolved imaging: measuring lifetimes in an image.Robert M. Clegg, Oliver Holub, Christoph Gohlke — 2003
• Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides.B. Munch-Petersen, L. Cloos, Gerda Tyrsted — 1991
• 'The metabolism of tumours': 70 years later.Gregg L. Semenza, Dmitri Artemov, Atul Bedi — 2001
• Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.Wei Chen, Timothy F. Cloughesy, Nirav Kamdar — 2005
• Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?D. Cobben, Philip H. Elsinga, Harald J. Hoekstra — 2004
• Current constructs and targets in clinical development for antibody-based cancer therapy.P. Markus Deckert — 2009
• [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?G. Halter, Andreas K. Buck, Holger Schirrmeister — 2004
• Cancer's sweet tooth.Thi Bui, Craig B. Thompson — 2006
• Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiographyMarie‐France Bellin, L. Lebleu, Jean‐Baptiste Méric — 2003
• Classification and basic properties of contrast agents for magnetic resonance imaging.Carlos F. G. C. Geraldes, Sophie Laurent — 2009
• In vivo Diagnosis of Epidermal Growth Factor Receptor Expression using Molecular Imaging with a Cocktail of Optically Labeled Monoclonal AntibodiesTristan Barrett, Yoshinori Koyama, Yukihiro Hama — 2007
• Safety of Strong, Static Magnetic FieldsJohn F. Schenck — 2000
• MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (combidex): Preliminary observationsMukesh G. Harisinghani, Sanjay Saini, Gregory J. Slater — 1997
• SPECT and PET imaging of EGF receptors with site-specifically labeled EGF and dimeric EGF.Zoya Levashova, Marina V. Backer, George Horng — 2009
• Molecular imaging of cancer—evaluating characters of individual cancer by PET/SPECT imagingTsuneo Saga, Mitsuru Koizumi, Takako Furukawa — 2009
• Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agentsHenrik S. Thomsen — 2007
• Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.John R. Grierson, J. L. Schwartz, Mark Muzi — 2004
• Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Edward F. Patz, Val J. Lowe, John M. Hoffman — 1993

Cited by

• Integration of cell biology, pharmacological modeling and statistical analysis: part I: cell biology and PK/PD in the Oncology paradigm.Revathi Ananthakrishnan, Sandeep Menon — 2012
• Single photon emission computed tomography tracer.Hans‐Jürgen Pietzsch, Constantin Mamat, Cristina Müller — 2013
• Synthetic routes to the tumour proliferation biomarker FLT and ProTide analogues for PET imagingWinnie Velanguparackel — 2014
• FDG PET/CT imaging in canine cancer patients.Anders E. Hansen, Fintan J. McEvoy, Svend Aage Engelholm — 2011
• THE BIOLOGICAL EFFECTS OF PET SCANS WITH 18 F-FDG IN MICEKristina Taylor — 2011
• Development of membrane type‐1 matrix metalloproteinase‐specific activatable fluorescent probe for malignant tumor detectionYoichi Shimizu, Takashi Temma, Kohei Sano — 2011
• In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour modelAlessa Pardo, Michael Stöcker, Florian Kampmeier — 2012
• Target-cancer cell specific activatable fluorescence imaging Probes: Rational Design and in vivo ApplicationsHisataka Kobayashi, Peter L. Choyke — 2010
• Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesMark Howell, C. Wang, Azza A. Mahmoud — 2013
• Rhodamine-deoxylactam functionalized poly[styrene-alter-(maleic acid)]s as lysosome activatable probes for intraoperative detection of tumorsLi Zhu, Yunlong Song, Yuhui Yang — 2012
• Point-of-care pathology with miniature microscopesJonathan Liu, Nathan O. Loewke, Michael J. Mandella — 2011
• NEAR-INFRARED DYES: Probe Development and Applications in Optical Molecular ImagingDonald D. Nolting, John C. Gore, Wellington Pham — 2011
• Imaging the life and death of tumors in living subjects: Preclinical PET imaging of proliferation and apoptosis.Quang‐Dé Nguyen, Eric O. Aboagye — 2010
• Multiplex photoacoustic molecular imaging using targeted silica-coated gold nanorodsCarolyn L. Bayer, Yun-Sheng Chen, Seungsoo Kim — 2011
• Dual-Modality Optical/PET Imaging of PARP1 in GlioblastomaGiuseppe Carlucci, Brandon Carney, Christian Brand — 2015
• Characterization of nanoparticle-based contrast agents for molecular magnetic resonance imagingLiang Shan, Arvind Chopra, Kam Leung — 2012
• MRI of prostate stem cell antigen expression in prostate tumors.Jing Ren, Zhuoli Zhang, Fang Wang — 2012
• Trends in Fluorescence Image-guided Surgery for GliomasJonathan Liu, Daphne Meza, Nader Sanai — 2014
• The role and future potential of fluorinated biomarkers in positron emission tomographyStephen Daniels, Siti Farah Md Tohid, Winnie Velanguparackel — 2010
• Rational Design of a Triple Reporter Gene for Multimodality Molecular ImagingYa‐Ju Hsieh, Luen Hwu, Chien‐Chih Ke — 2014

Related papers

• Bioresponsive probes for molecular imaging: concepts and in vivo applications.Sander M. J. van Duijnhoven, Marc S. Robillard, Sander Langereis — 2015
• In Vivo Molecular Imaging for Biomedical Analysis and TherapiesMikako Ogawa, Hideo Takakura — 2018
• New in vivo optical molecular imaging modalitiesPing Wu, Jie Tian, Di Dong — 2011
• In Vivo Molecular Imaging.Hideo Saji — 2017
• In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road AheadYingfeng Tu, Lei Jiang, Ruiping Zhang — 2015
• In vivo optical molecular imaging: principles and signal processing issuesJong Chul Ye, K. J. Webb, Rick P. Millane — 2005
• Molecular imaging of enzyme activity in vivo using activatable probesRunqi Yan, Deju Ye — 2016
• In vivo optical imaging in arthritis--an enlightening future?Luke Gompels, Ngee Han Lim, Tonia L. Vincent — 2010
• Molecular imaging IIKing C. Li — 2004